| abstract |
The disclosure relates to substituted 6-H-1,3,4-thiadiazine-2-imines of general formula (I), in which (II) represents a morpholine, thiomorpholine, piperidine, pyrrolidine or hexamethylene imine fragment, or to the pharmacologically acceptable salts of said compounds, to their use as anaesthetising, cardiovascular and hypometabolic agents and to pharmaceutical compositions containing them. |